These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32552069)
1. Image-guided thermal ablation of central renal tumors with retrograde cold pyeloperfusion technique: a monocentric experience. Mauri G; Rossi D; Bonomo G; Camisassi N; Della Vigna P; Maiettini D; Varano GM; Monfardini L; Mascagni L; Orsi F Int J Hyperthermia; 2020; 37(1):660-667. PubMed ID: 32552069 [No Abstract] [Full Text] [Related]
2. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors. Dai Y; Covarrubias D; Uppot R; Arellano RS J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657 [TBL] [Abstract][Full Text] [Related]
3. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317 [TBL] [Abstract][Full Text] [Related]
4. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients. Zhou W; Herwald SE; Uppot RN; Arellano RS Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Safety and Efficacy of Percutaneous Microwave Ablation of Central Versus Peripheral Renal Cell Carcinoma. An TJ; Arellano RS Cardiovasc Intervent Radiol; 2021 Feb; 44(2):281-288. PubMed ID: 33078234 [TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Retrograde Pyeloperfusion for Ureteral Protection during Renal Tumor Cryoablation. Marion JT; Schmitz JJ; Schmit GD; Kurup AN; Welch BT; Pasternak JJ; Boorjian SA; Leibovich BC; Atwell TD; Thompson RH J Vasc Interv Radiol; 2020 Aug; 31(8):1249-1255. PubMed ID: 32457011 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center. Zhou W; Uppot RN; Feldman AS; Arellano RS AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572 [TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. Wah TM; Koenig P; Irving HC; Gervais DA; Mueller PR J Vasc Interv Radiol; 2005 Nov; 16(11):1551-5. PubMed ID: 16319166 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of antegrade pyeloperfusion to protect the renal pelvis in kidney microwave ablation using an in vivo swine model. Isfort P; Penzkofer T; Tanaka T; Bruners P; Westphal S; Kennes LN; Schmitz-Rode T; Kuhl CK; Mahnken AH Invest Radiol; 2013 Dec; 48(12):863-8. PubMed ID: 24002078 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study. Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G; LaganĂ D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792 [TBL] [Abstract][Full Text] [Related]
13. Safety and Technical Feasibility of Percutaneous Renal Cryoablation of Central Tumors without Pyeloperfusion. Pigg RA; Raja JY; Babar T; Li Y; Li M; Huang J; Gunn AJ J Vasc Interv Radiol; 2024 Apr; 35(4):533-540. PubMed ID: 38219902 [TBL] [Abstract][Full Text] [Related]
14. Real-Time US-CT fusion imaging for guidance of thermal ablation in of renal tumors invisible or poorly visible with US: results in 97 cases. Mauri G; Monfardini L; Della Vigna P; Montano F; Bonomo G; Buccimazza G; Camisassi N; Rossi D; Maiettini D; Varano GM; Solbiati L; Orsi F Int J Hyperthermia; 2021; 38(1):771-776. PubMed ID: 33971779 [TBL] [Abstract][Full Text] [Related]
15. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up. Forauer AR; Dewey BJ; Seigne JD Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958 [TBL] [Abstract][Full Text] [Related]
16. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma]. Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026 [TBL] [Abstract][Full Text] [Related]